Zacks Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5M | Buy |
246,951
+428
| +0.2% | +$46K | 0.23% | 113 |
|
|
2025
Q1 | $24.9M | Buy |
246,523
+6,929
| +3% | +$699K | 0.23% | 111 |
|
|
2024
Q4 | $21.4M | Sell |
239,594
-16,224
| -6% | -$1.45M | 0.2% | 120 |
|
|
2024
Q3 | $21.4M | Buy |
255,818
+17,891
| +8% | +$1.5M | 0.19% | 128 |
|
|
2024
Q2 | $18.3M | Buy |
237,927
+79,252
| +50% | +$6.1M | 0.21% | 116 |
|
|
2024
Q1 | $10.9M | Buy |
+158,675
| New | +$10.9M | 0.12% | 150 |
|
|
2020
Q1 | – | Sell |
-5,128
| Closed | -$232K | – | 504 |
|
|
2019
Q4 | $232K | Buy |
+5,128
| New | +$232K | ﹤0.01% | 507 |
|
|
2017
Q1 | – | Sell |
-16,190
| Closed | -$350K | – | 645 |
|
|
2016
Q4 | $350K | Hold |
16,190
| – | – | 0.01% | 482 |
|
|
2016
Q3 | $385K | Buy |
+16,190
| New | +$385K | 0.01% | 473 |
|